Eye Journal
Response to Dr Clearkin – (Eye 28, 1523 (December 2014))
Response to Dr Clearkin Eye 28, 1523 (December 2014). doi:10.1038/eye.2014.205 Authors: G Williams & J A Olson
Vitreoretinal surgery for inadvertent intralenticular Ozurdex implant – (Eye 28, 1523 (December 2014))
Vitreoretinal surgery for inadvertent intralenticular Ozurdex implant Eye 28, 1523 (December 2014). doi:10.1038/eye.2014.192 Authors: K Chalioulias & M M K Muqit
Reply to ‘Vitreoretinal surgery for inadvertent intralenticular Ozurdex implant’ – (Eye 28, 1524 (December 2014))
Reply to ‘Vitreoretinal surgery for inadvertent intralenticular Ozurdex implant’ Eye 28, 1524 (December 2014). doi:10.1038/eye.2014.193 Authors: R Chhabra & S Mahmood
Comment on ‘Intrasilicone oil injection of bevacizumab at the end of retinal reattachment surgery for severe proliferative vitreoretinopathy’ – (Eye 28, 1525 (December 2014))
Comment on ‘Intrasilicone oil injection of bevacizumab at the end of retinal reattachment surgery for severe proliferative vitreoretinopathy’ Eye 28, 1525 (December 2014). doi:10.1038/eye.2014.198 Authors: N V Radke, T K Panakanti, S N Radke & R Ravikoti
Proliferative vitreoretinopathy and antivascular endothelial growth factor treatment – (Eye 28, 1525 (December 2014))
Proliferative vitreoretinopathy and antivascular endothelial growth factor treatment Eye 28, 1525 (December 2014). doi:10.1038/eye.2014.199 Authors: K Ghasemi Falavarjani & M Modarres